This article reviews the current status and controversies of the 3 commonly used antifibrinolytics-epsilon-aminocaproic acid, tranexamic acid and aprotinin-during liver transplantation. There is no general consensus on how, when or which antifibrinolytics should be used in liver transplantation. Alt
β¦ LIBER β¦
Current status of antifibrinolytic drugs
β Scribed by D. Ogston
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 532 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antifibrinolytics in orthotopic liver tr
β
Victor W. Xia; Randolph H. Steadman
π
Article
π
2004
π
John Wiley and Sons
π
English
β 97 KB
ChemInform Abstract: Current Status of P
β
Ernest Wong; Christen M. Giandomenico
π
Article
π
2010
π
John Wiley and Sons
β 24 KB
π 2 views
Current status of the development of tra
β
JosΓ© M PΓ©rez; Miguel A Fuertes; Carlos Alonso; Carmen Navarro-Ranninger
π
Article
π
2000
π
Elsevier Science
π
English
β 163 KB
The discovery in the 1990s of several trans-Pt complexes with in vitro and in vivo activity against tumor cells sensitive and/or resistant to cisplatin has forced the re-evaluation of the structure-activity relationships for platinum antitumor drugs. Because the determinant factors of cytotoxic acti
Capillary electrophoresis of drugs: Curr
β
Hiroyuki Nishi
π
Article
π
1999
π
John Wiley and Sons
π
English
β 323 KB
π 2 views
ChemInform Abstract: Current Status and
β
Masahiko Chikuma; Takaji Sato; Seiji Komeda
π
Article
π
2008
π
John Wiley and Sons
β 15 KB
π 2 views
Enantioseparation of chiral drugs and cu
β
Bezhan Chankvetadze
π
Article
π
2001
π
John Wiley and Sons
π
English
β 225 KB
π 1 views